Total Payments
$11,703
2024 Payments
$322.52
Companies
13
Transactions
30
Medicare Patients
137
Medicare Billing
$24,194
Payment Breakdown by Category
Research$8,611 (73.6%)
Travel$1,171 (10.0%)
Food & Beverage$1,029 (8.8%)
Other$892.33 (7.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $8,611 | 1 | 73.6% |
| Travel and Lodging | $1,171 | 3 | 10.0% |
| Food and Beverage | $1,029 | 25 | 8.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $892.33 | 1 | 7.6% |
Payments by Type
Research
$8,611
1 transactions
General
$3,092
29 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| F. Hoffmann-La Roche AG | $9,503 | 2 | $0 (2022) |
| Medtronic MiniMed, Inc. | $920.68 | 4 | $0 (2018) |
| Midmark Corporation | $600.88 | 2 | $0 (2017) |
| Abbott Laboratories | $145.84 | 1 | $0 (2024) |
| Genentech USA, Inc. | $108.03 | 6 | $0 (2021) |
| Dexcom, Inc. | $92.10 | 1 | $0 (2024) |
| Novo Nordisk Inc | $91.03 | 4 | $0 (2024) |
| ViiV Healthcare Company | $59.19 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $50.84 | 2 | $0 (2020) |
| Merck Sharp & Dohme Corporation | $37.91 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $322.52 | 4 | Abbott Laboratories ($145.84) |
| 2022 | $8,611 | 1 | F. Hoffmann-La Roche AG ($8,611) |
| 2021 | $142.45 | 8 | Genentech USA, Inc. ($89.92) |
| 2020 | $69.42 | 3 | GlaxoSmithKline, LLC. ($27.01) |
| 2019 | $952.12 | 4 | F. Hoffmann-La Roche AG ($892.33) |
| 2018 | $920.68 | 4 | Medtronic MiniMed, Inc. ($920.68) |
| 2017 | $684.72 | 6 | Midmark Corporation ($600.88) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/01/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $92.10 | General |
| Category: Endocrinology | ||||||
| 06/10/2024 | ViiV Healthcare Company | — | Food and Beverage | In-kind items and services | $59.19 | General |
| 05/15/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $145.84 | General |
| Category: Diabetes Care | ||||||
| 02/29/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $25.39 | General |
| Category: Diabetes | ||||||
| 06/30/2022 | F. Hoffmann-La Roche AG | Xolair (Biological) | — | In-kind items and services | $8,610.67 | Research |
| Study: ASTHMA EXACERBATION REDUCTION IN ADULTS WITH AIRWAY BRONCHODILATOR REVERSIBILITY AFTER OMALIZUMAB TREATMENT • Category: Immunology | ||||||
| 10/20/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.65 | General |
| Category: NEUROSCIENCE | ||||||
| 07/30/2021 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Immunology | ||||||
| 06/16/2021 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Respiratory | ||||||
| 05/14/2021 | Genentech USA, Inc. | Xolair (Biological), Actemra, Esbriet | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Immunology | ||||||
| 04/30/2021 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Immunology | ||||||
| 04/09/2021 | Genentech USA, Inc. | Xolair (Biological), Actemra, Esbriet | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Immunology | ||||||
| 03/30/2021 | Genentech USA, Inc. | Xolair (Biological), Actemra, Esbriet | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Immunology | ||||||
| 12/22/2020 | Genentech USA, Inc. | Xolair (Biological), Esbriet | Food and Beverage | In-kind items and services | $18.11 | General |
| Category: Immunology | ||||||
| 07/31/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $24.30 | General |
| Category: Diabetes | ||||||
| 01/29/2020 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.01 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2019 | F. Hoffmann-La Roche AG | Xolair (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $892.33 | General |
| Category: Immunology | ||||||
| 07/08/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: Diabetes | ||||||
| 06/27/2019 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: RESPIRATORY | ||||||
| 02/27/2019 | AstraZeneca Pharmaceuticals LP | FASENRA (Drug) | Food and Beverage | In-kind items and services | $17.40 | General |
| Category: Respiratory | ||||||
| 05/12/2018 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $59.87 | General |
| Category: Durable Pump | ||||||
| 05/12/2018 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Food and Beverage | In-kind items and services | $51.31 | General |
| Category: Durable Pump | ||||||
| 05/11/2018 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Travel and Lodging | In-kind items and services | $429.00 | General |
| Category: Durable Pump | ||||||
| 05/11/2018 | Medtronic MiniMed, Inc. | Minimed 670G System (Device) | Travel and Lodging | In-kind items and services | $380.50 | General |
| Category: Durable Pump | ||||||
| 12/05/2017 | Midmark Corporation | — | Travel and Lodging | In-kind items and services | $361.40 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ASTHMA EXACERBATION REDUCTION IN ADULTS WITH AIRWAY BRONCHODILATOR REVERSIBILITY AFTER OMALIZUMAB TREATMENT | F. Hoffmann-La Roche AG | $8,611 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 64 | 256 | $25,203 | $14,803 |
| 2022 | 2 | 31 | 80 | $8,729 | $4,689 |
| 2021 | 3 | 42 | 88 | $9,858 | $4,701 |
Total Patients
137
Total Services
424
Medicare Billing
$24,194
Procedure Codes
9
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 127 | $22,860 | $14,072 | 61.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 15 | 50 | $300.00 | $294.00 | 98.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 23 | $1,035 | $256.80 | 24.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2023 | 15 | 56 | $1,008 | $179.76 | 17.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 47 | $8,531 | $4,592 | 53.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 15 | 33 | $198.00 | $97.74 | 49.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 16 | 39 | $6,084 | $2,497 | 41.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 20 | $3,600 | $2,118 | 58.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 15 | 29 | $174.00 | $87.00 | 50.0% |
About Dr. Samuel Deleon, M.D
Dr. Samuel Deleon, M.D is a Pulmonary Disease healthcare provider based in Bronx, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1770589111.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Deleon, M.D has received a total of $11,703 in payments from pharmaceutical and medical device companies, with $322.52 received in 2024. These payments were reported across 30 transactions from 13 companies. The most common payment nature is "" ($8,611).
As a Medicare-enrolled provider, Deleon has provided services to 137 Medicare beneficiaries, totaling 424 services with total Medicare billing of $24,194. Data is available for 3 years (2021–2023), covering 9 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Bronx, NY
- Active Since 06/21/2005
- Last Updated 04/22/2015
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1770589111
Products in Payments
- Xolair (Biological) $9,611
- Minimed 670G System (Device) $920.68
- FREESTYLE LIBRE 3 (Device) $145.84
- Dexcom G6 Transmitter (Medical Supply) $92.10
- Ozempic (Drug) $68.25
- NUCALA (Biological) $50.84
- JANUVIA (Drug) $37.91
- QULIPTA (Drug) $32.54
- SOLIQUA (Drug) $23.15
- Victoza (Drug) $22.78
- FASENRA (Biological) $19.99
- FASENRA (Drug) $17.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Bronx
Dr. Raji Ayinla, M.d, M.D
Pulmonary Disease — Payments: $699,684
Pulmonary Disease $699,684
Peter Dicpinigaitis, Md, MD
Pulmonary Disease — Payments: $305,607
Pulmonary Disease $305,607
Neomi Shah, M.d, M.D
Pulmonary Disease — Payments: $16,397
Pulmonary Disease $16,397
Richard Deluca, M.d, M.D
Pulmonary Disease — Payments: $14,463
Pulmonary Disease $14,463
Dr. Manuel Cabrera, Md, MD
Pulmonary Disease — Payments: $7,790
Pulmonary Disease $7,790
Philip Klapper, Md, MD
Pulmonary Disease — Payments: $6,320
Pulmonary Disease $6,320